Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

DSCSA Phased Approach Suggested by Healthcare Distribution Alliance

  • Post author:PacConAdmin
  • Post published:June 26, 2023
  • Post category:Drug Industry Daily

Citing potential for supply disruptions to patient care, the Healthcare Distribution Alliance (HDA) has recommended a phased approach to the FDA's final implementation of the Drug Supply Chain Security Act…

Continue ReadingDSCSA Phased Approach Suggested by Healthcare Distribution Alliance

FTC Fines Promom Fertility App Developer $100K, Orders Protection of Consumer Data

  • Post author:PacConAdmin
  • Post published:June 26, 2023
  • Post category:Drug Industry Daily

Unauthorized sharing of users’ health data with several third parties — including Google — has gotten fertility app developer Easy Healthcare a $100,000 fine and a federal court order to…

Continue ReadingFTC Fines Promom Fertility App Developer $100K, Orders Protection of Consumer Data

Novo Nordisk’s Oral Semaglutide Sees 15 Percent Weight Loss and Better Diabetes Control

  • Post author:PacConAdmin
  • Post published:June 26, 2023
  • Post category:Drug Industry Daily

Multiple clinical trial results from two manufacturers posted in the past several days in The Lancet show high levels of success of both weight loss in obese adults and in…

Continue ReadingNovo Nordisk’s Oral Semaglutide Sees 15 Percent Weight Loss and Better Diabetes Control

Legislative Update — Week of June 26, 2023

  • Post author:PacConAdmin
  • Post published:June 26, 2023
  • Post category:Drug Industry Daily

As the 118th Congress continues, FDAnews will track important pending legislation to keep you updated on regulations that could impact your business. Source: Drug Industry Daily

Continue ReadingLegislative Update — Week of June 26, 2023

CMS Tries Again to Speed Breakthrough Device Approvals With New Coverage Process

  • Post author:PacConAdmin
  • Post published:June 23, 2023
  • Post category:Drug Industry Daily

Two years after its repeal of a rule that would have expedited Medicare coverage for FDA-cleared Breakthrough Devices, CMA Thursday issued a request for comment on a process to provide…

Continue ReadingCMS Tries Again to Speed Breakthrough Device Approvals With New Coverage Process

U.S. Government Suing Gilead for $1 Billion Over HIV PrEP Drug Patent Case

  • Post author:PacConAdmin
  • Post published:June 23, 2023
  • Post category:Drug Industry Daily

The U.S. government filed an appeal of a jury’s recent decision in the CDC patent infringement case involving Gilead’s HIV-prevention regimen, seeking $1 billion in compensation against Gilead’s $10 billion…

Continue ReadingU.S. Government Suing Gilead for $1 Billion Over HIV PrEP Drug Patent Case

Jazz Pharma Sues FDA, Claiming Approval of Avadel’s Narcolepsy Drug is Unlawful

  • Post author:PacConAdmin
  • Post published:June 23, 2023
  • Post category:Drug Industry Daily

The Orphan Drug Act should give Jazz Pharmaceuticals the full seven years of exclusivity for its blockbuster narcolepsy drug, Xywav, says Jazz in its suit against the FDA, claiming the…

Continue ReadingJazz Pharma Sues FDA, Claiming Approval of Avadel’s Narcolepsy Drug is Unlawful

Psychedelic Drug Development is Subject of New FDA Draft Guidance

  • Post author:PacConAdmin
  • Post published:June 23, 2023
  • Post category:Drug Industry Daily

Addressing growing interest in the therapeutic potential of psychedelic drugs, the FDA has published a draft guidance noting multiple unique considerations for psychedelic drug development programs and challenges in designing…

Continue ReadingPsychedelic Drug Development is Subject of New FDA Draft Guidance

FTC Slams District Court Decision, Supports Pharmacies in Bystolic Antitrust Case

  • Post author:PacConAdmin
  • Post published:June 22, 2023
  • Post category:Drug Industry Daily

The FTC has filed an amicus brief urging a U.S. appeals court to side with the plaintiffs in a case that alleges Forest Laboratories paid several generics producers millions of…

Continue ReadingFTC Slams District Court Decision, Supports Pharmacies in Bystolic Antitrust Case

Industry IRA Complaints Continue to Mount as PhRMA and Other Groups File Suit

  • Post author:PacConAdmin
  • Post published:June 22, 2023
  • Post category:Drug Industry Daily

PhRMA joined the constitutional showdown over the Inflation Reduction Act (IRA) by filing a complaint on Wednesday in the U.S. District Court for the Western District of Texas. Source: Drug…

Continue ReadingIndustry IRA Complaints Continue to Mount as PhRMA and Other Groups File Suit
  • Go to the previous page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 385
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.